Clinical Development and Marketed Products

TB Alliance manages the largest pipeline of new TB drugs in history and has advanced multiple products to market. Projects with the potential to have the greatest impact on the disease, while being cost-effective and simple to administer, are prioritized. Our pipeline is updated on a quarterly basis, with studies added after enrollment has initiated and removed after the completion of the clinical study report. For the latest status of our trials, please visit or contact us to schedule a briefing.

Phase 2

Phase 3

Marketed Products

These products have come to market as a result of the dedicated efforts of TB Alliance and partners.